Research output per year
Research output per year
Personal profile
Research interests
Application of whole genomic technologies (e.g. DNA microarrays) and biomedical informatics approaches to the molecular characterization of breast cancer and other malignancies. Development and validation of genome-based biomarkers for the prognosis and targeted therapeutic management of cancer.
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Mark Watson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis
Karlow, J. A., Devarakonda, S., Xing, X., Jang, H. S., Govindan, R., Watson, M. & Wang, T., Aug 1 2022, In: Cancer research. 82, 15, p. 2692-2703 12 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastatic NSCLC
Hensing, T. A., Wang, X., Stinchcombe, T. E., Gao, J., Knopp, M. V., Watson, M., Dudek, A. Z., Graziano, S. L., Patel, J. D., Faller, B. A., Dragnev, K. H., Kozono, D. & Vokes, E. E., Aug 2021, In: JTO Clinical and Research Reports. 2, 8, 100208.Research output: Contribution to journal › Article › peer-review
Open Access -
A microfluidic-based filtration system to enrich for bone marrow disseminated tumor cells from breast cancer patients
Pillai, S. G., Siddappa, C. M., Ma, C., Snider, J., Kaushal, M., Watson, M. A. & Aft, R., May 2021, In: PloS one. 16, 5 May, e0246139.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Association of Immunophenotype with Pathologic Complete Response to Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Secondary Analysis of the BrighTNess Phase 3 Randomized Clinical Trial
Filho, O. M., Stover, D. G., Asad, S., Ansell, P. J., Watson, M., Loibl, S., Geyer, C. E., Bae, J., Collier, K., Cherian, M., O'Shaughnessy, J., Untch, M., Rugo, H. S., Huober, J. B., Golshan, M., Sikov, W. M., Von Minckwitz, G., Rastogi, P., Maag, D., Wolmark, N., & 2 others, Apr 2021, In: JAMA oncology. 7, 4, p. 603-608 6 p.Research output: Contribution to journal › Article › peer-review
Open Access23 Scopus citations -
Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging
Arthur, L., Esaulova, E., Mogilenko, D. A., Tsurinov, P., Burdess, S., Laha, A., Presti, R., Goetz, B., Watson, M. A., Goss, C. W., Gurnett, C. A., Mudd, P. A., Beers, C., O’Halloran, J. A. & Artyomov, M. N., Jun 2021, In: Nature Aging. 1, 6, p. 535-549 15 p.Research output: Contribution to journal › Article › peer-review
Open Access13 Scopus citations